Hughes A R, Takemura H, Putney J W
Calcium Regulation Section, National Institute of Environmental Health Sciences, National Institute of Health, North Carolina.
Cell Calcium. 1989 Nov-Dec;10(8):519-25. doi: 10.1016/0143-4160(89)90013-4.
The effects of the beta-adrenoceptor agonist, isoprenaline, on Ca2+ mobilization and inositol phosphate formation in parotid acinar cells were examined. Isoprenaline (2 microM) failed to increase cytosolic [Ca2+] in acinar cells, as measured by Fura-2 fluorescence, even in the presence of a phosphodiesterase inhibitor. Likewise, neither the 8-bromo nor the dibutyryl derivatives of cAMP (both at 2 mM concentration) increased [Ca2+]i. However, in confirmation of results previously published, a higher concentration of isoprenaline (200 microM) increased cytosolic [Ca2+]i of rat parotid acinar cells, from 104 +/- 4 nM to 151 +/- 18 nM. The increase in [Ca2+]i in response to isoprenaline, while transient in the absence of extracellular Ca2+, was sustained in Ca2(+)-containing medium. This isoprenaline-stimulated Ca2+ signal was more potently antagonized by phentolamine than by propranolol, suggesting that the higher concentration of isoprenaline activated alpha-adrenoceptors. Furthermore, the Ca2+ signal generated in response to the alpha-adrenoceptor agonist, phenylephrine, also was blocked by the same concentrations of propranolol necessary to block the effects of isoprenaline, suggesting that propranolol may block alpha-adrenoceptors under certain experimental conditions. The high concentration of (-)isoprenaline (200 microM) also increased inositol (1,4,5) trisphosphate and inositol (1,3,4) trisphosphate formation 45% within 30 s. Analogous to the increase in intracellular Ca2+, the formation of inositol phosphates stimulated by isoprenaline was more potently antagonized by the alpha-adrenoceptor antagonist, phentolamine, than by the beta-adrenoceptor antagonist, propranolol, again suggesting that isoprenaline interacts with alpha-adrenoceptors on parotid cells. Thus, the effects of isoprenaline on [Ca2+]i do not appear to be mediated by cAMP.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了β-肾上腺素能受体激动剂异丙肾上腺素对腮腺腺泡细胞中Ca2+动员和肌醇磷酸形成的影响。通过Fura-2荧光测量,即使存在磷酸二酯酶抑制剂,异丙肾上腺素(2 microM)也未能增加腺泡细胞中的胞质[Ca2+]。同样,cAMP的8-溴衍生物和二丁酰衍生物(浓度均为2 mM)均未增加[Ca2+]i。然而,正如先前发表的结果所证实的,较高浓度的异丙肾上腺素(200 microM)可使大鼠腮腺腺泡细胞的胞质[Ca2+]i从104±4 nM增加到151±18 nM。在无细胞外Ca2+时,异丙肾上腺素引起的[Ca2+]i增加是短暂的,而在含Ca2+的培养基中则持续存在。酚妥拉明比普萘洛尔更有效地拮抗这种异丙肾上腺素刺激的Ca2+信号,这表明较高浓度的异丙肾上腺素激活了α-肾上腺素能受体。此外,α-肾上腺素能受体激动剂去氧肾上腺素产生的Ca2+信号也被阻断异丙肾上腺素作用所需的相同浓度的普萘洛尔所阻断,这表明普萘洛尔在某些实验条件下可能阻断α-肾上腺素能受体。高浓度的(-)异丙肾上腺素(200 microM)在30秒内也使肌醇(1,4,5)三磷酸和肌醇(1,3,4)三磷酸的形成增加了45%。与细胞内Ca2+的增加类似,异丙肾上腺素刺激的肌醇磷酸形成被α-肾上腺素能受体拮抗剂酚妥拉明比β-肾上腺素能受体拮抗剂普萘洛尔更有效地拮抗,这再次表明异丙肾上腺素与腮腺细胞上的α-肾上腺素能受体相互作用。因此,异丙肾上腺素对[Ca2+]i的作用似乎不是由cAMP介导的。(摘要截断于250字)